Therapeutic effects of cell-permeant peptides that activate G proteins downstream of growth factors.
about
Heterotrimeric G proteins as emerging targets for network based therapy in cancer: End of a long futile campaign striking heads of a HydraActivation of G proteins by GIV-GEF is a pivot point for insulin resistance and sensitivity.Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon CancerEfficient therapeutic delivery by a novel cell-permeant peptide derived from KDM4A protein for antitumor and antifibrosis.The untapped potential of tyrosine-based G protein signaling.Heterotrimeric G protein signaling via GIV/Girdin: Breaking the rules of engagement, space, and time.The Gαi-GIV binding interface is a druggable protein-protein interactionMolecular mechanism of Gαi activation by non-GPCR proteins with a Gα-Binding and Activating motif.G protein coupled growth factor receptor tyrosine kinase: no longer an oxymoron.Prognostic impact of total and tyrosine phosphorylated GIV/Girdin in breast cancers.Biochemical, Biophysical and Cellular Techniques to Study the Guanine Nucleotide Exchange Factor, GIV/Girdin.Activation of Parathyroid Hormone 2 Receptor Induces Decorin Expression and Promotes Wound Repair.Specific inhibition of GPCR-independent G protein signaling by a rationally engineered protein.Membrane Recruitment of the Non-receptor Protein GIV/Girdin (Gα-interacting, Vesicle-associated Protein/Girdin) Is Sufficient for Activating Heterotrimeric G Protein Signaling.A biochemical and genetic discovery pipeline identifies PLCδ4b as a nonreceptor activator of heterotrimeric G-proteins
P2860
Q26801694-850D9128-D389-4A7F-B183-34F5392B84F9Q36274510-91898DB3-EA91-4B18-A52A-EA848A4BF0DEQ37100057-A00B2EFE-245F-4A81-93F9-C1A5272C0DE5Q37580169-A29C68E4-81E7-4787-BBB4-550346784EDCQ38710732-057D33D1-0931-484B-987D-E5794E1C264AQ38734798-A5E4FBEA-9040-485A-B5EF-AA0A08C27A03Q41447286-55989907-2385-418F-B1C6-6E619946E2ABQ42150320-30109F8F-21B4-4F9A-9EFC-7E57ECA76B39Q42594360-669753BA-F895-44B0-9BB1-6F16BBAEF18CQ42705481-9691394B-E1D7-49B9-9B0F-0CD0C8AA2A02Q45909882-1899C5C0-A924-4D2C-8607-2481E0A16CF0Q46300807-AA992A31-EBBC-43B8-A0EE-270F5DE6330FQ47407152-343596DC-53E5-429A-918A-F3FB79FBC3C9Q51316906-620CDB89-4675-40AC-8EF1-130F888F073CQ58757963-E2A1A54B-94F8-4FEA-95A3-2D3096FB2770
P2860
Therapeutic effects of cell-permeant peptides that activate G proteins downstream of growth factors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Therapeutic effects of cell-pe ...... downstream of growth factors.
@ast
Therapeutic effects of cell-pe ...... downstream of growth factors.
@en
type
label
Therapeutic effects of cell-pe ...... downstream of growth factors.
@ast
Therapeutic effects of cell-pe ...... downstream of growth factors.
@en
prefLabel
Therapeutic effects of cell-pe ...... downstream of growth factors.
@ast
Therapeutic effects of cell-pe ...... downstream of growth factors.
@en
P2093
P2860
P356
P1476
Therapeutic effects of cell-pe ...... s downstream of growth factors
@en
P2093
Inmaculada Lopez-Sanchez
Krishna K Midde
Nicholas Kalogriopoulos
Pradipta Ghosh
Richard L Gallo
Ying Dunkel
P2860
P304
P356
10.1073/PNAS.1505543112
P407
P577
2015-04-29T00:00:00Z